WO2006005940A3 - Monoclonal anti-glut2 antibody - Google Patents

Monoclonal anti-glut2 antibody Download PDF

Info

Publication number
WO2006005940A3
WO2006005940A3 PCT/GB2005/002727 GB2005002727W WO2006005940A3 WO 2006005940 A3 WO2006005940 A3 WO 2006005940A3 GB 2005002727 W GB2005002727 W GB 2005002727W WO 2006005940 A3 WO2006005940 A3 WO 2006005940A3
Authority
WO
WIPO (PCT)
Prior art keywords
antibody
monoclonal anti
glut2
glut2 antibody
recognises
Prior art date
Application number
PCT/GB2005/002727
Other languages
French (fr)
Other versions
WO2006005940A2 (en
Inventor
Peter Collins
Archie Roberston
Original Assignee
Riverside Biosciences Ltd
Peter Collins
Archie Roberston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riverside Biosciences Ltd, Peter Collins, Archie Roberston filed Critical Riverside Biosciences Ltd
Publication of WO2006005940A2 publication Critical patent/WO2006005940A2/en
Publication of WO2006005940A3 publication Critical patent/WO2006005940A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A monoclonal antibody that recognises glucose transporter 2 (GLUT2) is described, as well as a hybridoma that produces the antibody. The antibody may be used to identify or isolate embryonic or fetal cells, for example in an in vitro method of prenatal diagnosis.
PCT/GB2005/002727 2004-07-13 2005-07-13 Monoclonal anti-glut2 antibody WO2006005940A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0415644.4 2004-07-13
GB0415644A GB0415644D0 (en) 2004-07-13 2004-07-13 Monoclonal antibody

Publications (2)

Publication Number Publication Date
WO2006005940A2 WO2006005940A2 (en) 2006-01-19
WO2006005940A3 true WO2006005940A3 (en) 2006-04-27

Family

ID=32893490

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2005/002727 WO2006005940A2 (en) 2004-07-13 2005-07-13 Monoclonal anti-glut2 antibody

Country Status (2)

Country Link
GB (1) GB0415644D0 (en)
WO (1) WO2006005940A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2215474A4 (en) 2007-07-16 2012-07-18 Avaxia Biologics Inc Antibody therapy for modulating function of intestinal receptors
EP2244735A4 (en) 2007-10-02 2011-02-23 Avaxia Biologics Inc Antibody therapy for use in the digestive tract

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040746A1 (en) * 1997-03-08 1998-09-17 The University Of Dundee Prenatal diagnostic methods
WO2002021132A2 (en) * 2000-09-08 2002-03-14 University Of Dundee Cell assays

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040746A1 (en) * 1997-03-08 1998-09-17 The University Of Dundee Prenatal diagnostic methods
US6331395B1 (en) * 1997-03-08 2001-12-18 The University Of Dundee Prenatal diagnostic methods
WO2002021132A2 (en) * 2000-09-08 2002-03-14 University Of Dundee Cell assays

Also Published As

Publication number Publication date
WO2006005940A2 (en) 2006-01-19
GB0415644D0 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
WO2005100401A3 (en) Monoclonal antibodies with specificity for fetal erythroid cells
WO2008045962A3 (en) Methods and materials related to anti-a (beta) antibodies
WO2006113881A3 (en) Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood
WO2006094192A3 (en) Humanized l243 antibodies
WO2007110678A3 (en) Neutralizing antibodies and methods of use thereof
WO2007095506A8 (en) Oligosaccharide modification and labeling of proteins
PT1415158E (en) METHOD FOR SELECTING CELLS EXPRESSING ANTIBODIES
WO2007079183A3 (en) Placental stem cell populations
TW200700092A (en) Tigecycline compositions and methods of preparation
WO2003002972A3 (en) Method and device for obtaining a sample with three-dimensional microscopy
ATE486610T1 (en) ANTI-GLYPICAN-3 ANTIBODIES
WO2000031237A3 (en) Method of cloning porcine animals
WO2008002712A3 (en) Systems and methods for integrating outsourcers
EP1362093A4 (en) Rapid production of monoclonal antibodies
WO2006034427A3 (en) Diagnosis of fetal aneuploidy
WO2007106545A3 (en) Propagation of primary cells
ATE462012T1 (en) EZYMATIC PROCESS FOR PRODUCING 2-O-GLYCERYL-ALPHA-D-GLUCOPYRANOSIDE
WO2007044418A3 (en) Cell culture media, kits and methods of use
WO2005116252A8 (en) Methods for evaluating ribonucleotide sequences
WO2015035239A3 (en) Reagents and methods for screening mps i, ii, iiia, iiib, iva, vi, and vii
WO2002010337A3 (en) Method of cloning porcine animals
WO2008132753A3 (en) Methods and kits for detecting fetal cells in the maternal blood
ATE429449T1 (en) ANTI-FAS LIGAND ANTIBODIES AND TESTING METHOD USING THE SAME
WO2004035742A3 (en) Sets of digital antibodies directed against short epitopes, and methods using same
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase